A case for deprescribing at the end of life

For older people with advanced cancer, continued prescribing of some drugs may not be clinically useful. A recent cohort study in Sweden has assessed 151,201 adults aged ≥65 years (mean age, 81.3 years [SD, 8.1 years]) who died with cancer between 2007-2013, assessing...

Barcoding technology on unit dose packaging in hospitals.

The Society of Hospital Pharmacists of Australia (SHPA) have issued a detailed position statement on barcoding technology on unit dose packaging in hospitals. The statement can be read in full here, but the conclusion reads: “The introduction of unit dose...

Regulatory warnings about medications don’t always align

American researchers have recently evaluated the extent of agreement of medicines safety recommendations between drug regulatory authorities in Australia, Canada, the United Kingdom and the United States, examining this issue over a period of 10 years. For 680...

Some PPIs reduce the effects of clopidogrel

Korean researchers have examined the effects of co-administration of proton pump inhibitors (PPIs) or statins with clopidogrel, using pharmacoepidemiological data. The basis for the study was that PPIs or CYP3A4‐metabolized statins might increase thee risk for...

Who needs clinical pharmacy input in hospital?

A prognostic model called the Medicines Optimisation Assessment Tool (MOAT) has recently been developed in the United Kingdom to identify patients with moderate to severe risk of preventable medication-related problems (MRPs) who require the most input from clinical...